"The FDA's approval of colchicine confirms that we are entering a new era of patient care," said one veteran cardiologist familiar with the drug. 

The three-year grant will help the ADA fund two pilot programs and engage with healthcare professionals and other industry leaders.

When patients wear VR glasses during transcatheter aortic valve replacement, they say it helps time go by more quickly and reduces anxiety.

The collaboration, announced at ASE 2023, was launched in the name of patient access. 

Attaching ECG sensors to the handles of shopping carts could help identify signs of atrial fibrillation in patients who don't even realize they have it. 

Cardiovascular Associates of America, which has already had an eventful 2023, announced a new acquisition that helps expand its footprint in the Sunshine State. 

Diagnosing, treating and managing aortic stenosis is often a challenging task, especially when the patient has a long life expectancy. Shared decision-making can make a significant impact, helping ensure the patient's values and preferences are taken into consideration. 

The FDA Circulatory System Devices Panel is set to review the PMA submissions for the ReCor and Medtronic renal denervation systems to treat patients with uncontrolled hypertension.

Anumana, Pfizer and Mayo Clinic all worked together to develop the advanced algorithm. The groups are now targeting full regulatory approval in the U.S., Europe and Japan.

Artificial intelligence will be one of the hottest topics at the upcoming American Society of Echocardiography meeting in National Harbor, Maryland.